Collaborative Drug Discovery selected by Curve Therapeutics to digitalize its drug discovery platform
Innovative end-to-end scientific research to be managed in CDD Vault
SAN FRANCISCO, Dec. 18, 2020 /PRNewswire/ Collaborative Drug Discovery (CDD) has today announced that its CDD Vault platform will be implemented by Curve Therapeutics Ltd. (Southampton, UK) to manage its genetically-encoded Microcycle platform and the functional hits and leads generated from it. Curve is an innovative drug discovery company that has developed a screening platform that directly identifies functional modulators of disease targets in their native cellular environment.
CDD Vault is a ubiquitous, hosted platform used by research teams at pharma, academia, and biotechs to store, mine and manage chemical, biological, and image data from the discovery process. It allows the secure and seamless sharing of data with external partners in real-time thus facilitating true collaborative discoveries.
BC Platforms delivers data platform for UK research consortium to improve detection of lung cancer
ZURICH and LONDON, Dec. 18, 2020 /PRNewswire/ BC Platforms, a global leader in clinical and genomic data management, analytics and access, today announced it is providing its discovery and research platform BC|INSIGHT to enable ground-breaking medical research into the early diagnosis of lung cancer in order to save lives. Lung cancer is the biggest cause of cancer death in the UK and worldwide.
The consortium is led by the Universities of Southampton and Leeds, together with healthcare, diagnostics and informatics companies, to test the best way of detecting cancers at a stage when they can still be cured, linking to the NHS England Lung Health Checks programme. In addition to BC Platforms, the research collaborators include Johnson & Johnson, Roche, Oncimmune, Inivata and others.
Coronavirus vaccines are being administered. Pfizer’s COVID-19 vaccine was the first to finish the final stage of testing – known as phase 3 – and the full results have been published. Having assessed the data, countries are beginning to authorise this vaccine for public use and roll it out.
Others are not too far behind. The Oxford/AstraZeneca vaccine is nearing the end of phase 3, and the research team has released interim figures from the trial. These are basically a sneak peek at how the testing is going, to confirm the vaccine is working as expected. Full phase 3 results are expected soon.
Researchers to explore new ways to diagnose early-stage lung cancer
Ground-breaking medical research in a consortium led by two UK universities will explore new ways to diagnose lung cancer earlier and save lives.
The Universities of Southampton and Leeds have come together with healthcare, diagnostics and informatics companies to test the best way of detecting cancers at a stage when they can still be cured, linking to the NHS England Targeted Lung Health Checks programme. The research collaborators include the Lung Cancer Initiative at Johnson & Johnson, Roche, Oncimmune, Inivata, BC Platforms and others.
The research, part of the Government s Early Diagnosis Mission to diagnose three-quarters of cancers at an early stage by 2028, is able to proceed thanks to approximately £3.5m-worth of funding from UK Research and Innovation s Industrial Strategy Challenge Fund (ISCF), part of a total investment of £10 million in the programme overall.
أوغور شاهين وأوزليم توريتشي شخصيتا «فاينانشيال تايمز» لعام 2020 aleqt.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from aleqt.com Daily Mail and Mail on Sunday newspapers.